Bioventus (BVS) Intangibles (2020 - 2026)
Bioventus (BVS) posted Intangibles of $359.7 million for Q1 2026, down 2.38% on a QoQ basis from $368.4 million in Q4 2025, and down 9.12% year-over-year from $395.7 million in Q1 2025.
Bioventus (BVS) Intangibles (2020 - 2026) Analysis & Trends
Bioventus' Intangibles history runs 7 years deep, the most recent figure standing at $359.7 million for Q1 2026.
- Quarterly Intangibles fell 9.12% year-over-year to $359.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $359.7 million (down 9.12% YoY) and the FY2025 annual result came in at $368.4 million, down 8.97% from the prior year.
- Intangibles was $359.7 million for Q1 2026 at Bioventus, down from $368.4 million in the prior quarter.
- Across five years, Intangibles topped out at $1.1 billion in Q4 2022 and bottomed at $359.7 million in Q1 2026.
- A 5-year average of $508.4 million and a median of $470.7 million in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2022 — Intangibles jumped 324.29% — and 2023, when it tumbled 53.27%.
- Bioventus' Intangibles stood at $639.9 million in 2022, then fell by 24.62% to $482.4 million in 2023, then fell by 16.09% to $404.7 million in 2024, then retreated by 8.97% to $368.4 million in 2025, then slipped by 2.38% to $359.7 million in 2026.
- Business Quant data shows BVS's Intangibles at $359.7 million in Q1 2026, $368.4 million in Q4 2025, and $377.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 17.88 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 5.52 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 10.15 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 7.06 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 1.23 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 62.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 1.91 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 882.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.14 Bn |
| 10 | Bioventus | 837.84 Mn | 801.99 Mn | 90.77 Mn | 359.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 359.66 Mn |
| Dec 31, 2025 | 368.42 Mn |
| Sep 27, 2025 | 377.40 Mn |
| Jun 28, 2025 | 386.95 Mn |
| Mar 29, 2025 | 395.73 Mn |
| Dec 31, 2024 | 404.73 Mn |
| Sep 28, 2024 | 414.81 Mn |
| Jun 29, 2024 | 424.55 Mn |
| Mar 30, 2024 | 470.67 Mn |
| Dec 31, 2023 | 482.35 Mn |
| Sep 30, 2023 | 493.32 Mn |
| Jul 1, 2023 | 505.22 Mn |
| Apr 1, 2023 | 516.04 Mn |
| Dec 31, 2022 | 639.85 Mn |
| Oct 1, 2022 | 1.06 Bn |
| Jul 2, 2022 | 666.52 Mn |
| Apr 2, 2022 | 681.37 Mn |
| Dec 31, 2021 | 695.19 Mn |
| Oct 2, 2021 | 248.79 Mn |
| Jul 3, 2021 | 257.85 Mn |